Cargando…

Effect of age and disease on bone mass in Japanese patients with schizophrenia

BACKGROUND: There have been a limited number of studies comparing bone mass between patients with schizophrenia and the general population. The aim of this study was to compare the bone mass of schizophrenia patients with that of healthy subjects in Japan. METHODS: We recruited patients (n = 362), a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugawara, Norio, Yasui-Furukori, Norio, Umeda, Takashi, Tsuchimine, Shoko, Fujii, Akira, Sato, Yasushi, Saito, Manabu, Furukori, Hanako, Danjo, Kazuma, Matsuzaka, Masashi, Takahashi, Ippei, Kaneko, Sunao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298460/ https://www.ncbi.nlm.nih.gov/pubmed/22348381 http://dx.doi.org/10.1186/1744-859X-11-5

Ejemplares similares

Body composition in patients with schizophrenia: Comparison with healthy controls
por: Sugawara, Norio, et al.
Publicado: (2012)

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2011)

Dietary patterns are associated with obesity in Japanese patients with schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2014)

Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population
por: Sugawara, Norio, et al.
Publicado: (2010)

No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan
por: Sugawara, Norio, et al.
Publicado: (2012)

Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals
por: Tsuchimine, Shoko, et al.
Publicado: (2013)

Body mass index and quality of life among outpatients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2013)

Cognitive function among hemodialysis patients in Japan
por: Odagiri, Gen, et al.
Publicado: (2011)

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan
por: Sugawara, Norio, et al.
Publicado: (2017)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2015)

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2014)

Hearing impairment and cognitive function among a community-dwelling population in Japan
por: Sugawara, Norio, et al.
Publicado: (2011)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga, Koji, et al.
Publicado: (2015)

Cognitive function and number of teeth in a community-dwelling population in Japan
por: Saito, Yuki, et al.
Publicado: (2013)

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari, Junji, et al.
Publicado: (2013)

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder
por: Tomita, Tetsu, et al.
Publicado: (2014)

ABO Blood Type and Personality Traits in Healthy Japanese Subjects
por: Tsuchimine, Shoko, et al.
Publicado: (2015)

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff
por: Tarakita, Natsumi, et al.
Publicado: (2018)

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response
por: Tomita, Tetsu, et al.
Publicado: (2014)

Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression
por: Tsuchimine, Shoko, et al.
Publicado: (2018)

Relationship between the lesion location of acute ischemic stroke and early depressive symptoms in Japanese patients
por: Metoki, Norifumi, et al.
Publicado: (2016)

Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations
por: Fujii, Akira, et al.
Publicado: (2009)

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
por: Tsuruga, Koji, et al.
Publicado: (2014)

Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia
por: Yamada, Momoka, et al.
Publicado: (2023)

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
por: Saruwatari, Junji, et al.
Publicado: (2014)

PS105. Effects of CYP2C19 genotype on steady-state plasma concentrations of escitalopram and desmetyl metabolite in Japanese depressed patients
por: Tsuchimine, Shoko, et al.
Publicado: (2016)

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
por: Kawamata, Yasushi, et al.
Publicado: (2021)

Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia
por: Sugawara, Norio, et al.
Publicado: (2019)

Survey of Health Literacy Among Japanese Outpatients with Mental Illness
por: Sato, Yoshiteru, et al.
Publicado: (2023)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda, Ayako, et al.
Publicado: (2013)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Factor structure of the University Personality Inventory in Japanese medical students
por: Sugawara, Norio, et al.
Publicado: (2020)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2019)

Update on the development of lurasidone as a treatment for patients with acute schizophrenia
por: Yasui-Furukori, Norio
Publicado: (2012)

PS108. Characteristics of escitalopram discontinuation syndrome
por: Norio-Furukori, Yasui, et al.
Publicado: (2016)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka, Masamichi, et al.
Publicado: (2014)

Worsened hypertension control induced by aripiprazole
por: Yasui-Furukori, Norio, et al.
Publicado: (2013)

Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan
por: Sugawara, Norio, et al.
Publicado: (2017)

Working status of caregivers for people with dementia: Analysis data from a Japanese Nationwide Survey
por: Sugawara, Norio, et al.
Publicado: (2020)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4s2lhvuek33mv129plvc1hr07l